Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
British Journal of Cancer|January 28, 2025
Semi-mechanistic efficacy model for PARP + ATR inhibitors-application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXsClaire C Villette, Nathalie Dupuy, Frances A Brightman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 2022
Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple MyelomaFloriane Lignet, Christina Esdar, Gina Walter-Bausch, et al.
British Journal of Cancer|November 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T J van Bussel, Ahmad Awada, Maja J A de Jonge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2019
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid TumorsGerald S Falchook, Razelle Kurzrock, Hesham M Amin, et al.
Frontiers in Immunology|June 7, 2014
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical StudiesPhilipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, et al.
Elife|December 10, 2016
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinasesPaul A Clarke, Maria-Jesus Ortiz-Ruiz, Robert TePoele, et al.
Pageof 3